cholesterol-lowering drugs might increase the risk of cancer

Patients are concerned about recent reports that many cholesterol-lowering drugs might increase the risk of cancer.

This was triggered by an article recently published in JAMA.

The authors suggest limiting the use of "statins" such as lovastatin (Mevacor)...and fibrates such as gemfibrozil (Lopid).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote